tiprankstipranks
Trending News
More News >
Akzo Nobel NV (NL:AKZA)
:AKZA
Advertisement

Akzo Nobel NV (AKZA) AI Stock Analysis

Compare
6 Followers

Top Page

NL:AKZA

Akzo Nobel NV

(AKZA)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 4o)
Rating:65Neutral
Price Target:
€63.00
▲(4.86% Upside)
Akzo Nobel NV's overall stock score reflects strong cash flow and gross profit margins, but is tempered by challenges in revenue growth and high leverage. Technical indicators suggest neutral momentum, while valuation metrics indicate potential overvaluation. The absence of earnings call and corporate events data limits further insights.

Akzo Nobel NV (AKZA) vs. iShares MSCI Netherlands ETF (EWN)

Akzo Nobel NV Business Overview & Revenue Model

Company DescriptionAkzo Nobel NV (AKZA) is a leading global paints and coatings company based in the Netherlands, specializing in the production of decorative paints, performance coatings, and specialty chemicals. With a strong presence in various sectors, including automotive, aerospace, marine, and construction, Akzo Nobel offers a wide range of products designed to protect and enhance surfaces. The company is known for its commitment to sustainability and innovation, providing high-quality solutions that meet the needs of its diverse customer base.
How the Company Makes MoneyAkzo Nobel generates revenue primarily through the sale of its paints, coatings, and specialty chemicals. Its revenue model is built on several key streams, including the sale of decorative paints to consumers and professionals, performance coatings for industrial applications, and specialty chemicals for various industries. The company benefits from strong brand recognition and a loyal customer base, which contribute to consistent sales. Additionally, Akzo Nobel engages in strategic partnerships and collaborations with other companies to expand its market reach and enhance product development. Factors such as increasing demand for sustainable products and innovations in coatings technology also play a significant role in driving the company's earnings.

Akzo Nobel NV Financial Statement Overview

Summary
Akzo Nobel NV shows strong cash flow generation and healthy gross profit margins. However, challenges in revenue growth and high leverage could impact future profitability and financial flexibility.
Income Statement
70
Positive
Akzo Nobel NV's income statement shows a mixed performance. The TTM (Trailing-Twelve-Months) gross profit margin is healthy at 39.85%, indicating efficient cost management. However, the net profit margin has decreased to 3.94%, reflecting pressure on bottom-line profitability. Revenue growth has been negative recently, with a decline of 1.48% in the TTM period, suggesting challenges in market expansion or competitive pressures. EBIT and EBITDA margins have also seen a decline, indicating reduced operational efficiency.
Balance Sheet
65
Positive
The balance sheet reveals a relatively high debt-to-equity ratio of 1.40 in the TTM period, indicating significant leverage which could pose financial risk. Return on equity is moderate at 9.25%, showing decent profitability relative to shareholder equity. The equity ratio stands at 29.44%, suggesting a balanced capital structure but with room for improvement in reducing debt levels.
Cash Flow
75
Positive
Cash flow analysis shows positive trends, with a free cash flow growth rate of 21.52% in the TTM period, indicating improved cash generation capabilities. The operating cash flow to net income ratio is 0.16, reflecting adequate cash conversion from earnings. The free cash flow to net income ratio is 0.59, suggesting a solid ability to generate cash relative to net income, despite some volatility in previous periods.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue10.53B10.71B10.67B10.85B9.59B8.53B
Gross Profit4.20B4.34B4.23B3.92B3.85B3.79B
EBITDA1.24B1.40B1.41B1.05B1.50B1.34B
Net Income415.00M542.00M442.00M352.00M829.00M630.00M
Balance Sheet
Total Assets14.17B14.25B14.90B14.74B13.88B13.18B
Cash, Cash Equivalents and Short-Term Investments1.57B1.47B1.78B1.79B1.21B1.86B
Total Debt5.85B5.37B5.56B5.88B3.55B2.89B
Total Liabilities9.79B9.43B10.36B10.19B8.24B7.23B
Stockholders Equity4.17B4.57B4.32B4.33B5.42B5.75B
Cash Flow
Free Cash Flow480.00M367.00M840.00M-29.00M317.00M962.00M
Operating Cash Flow814.00M673.00M1.12B263.00M605.00M1.22B
Investing Cash Flow-261.00M-132.00M-144.00M-1.09B-134.00M-427.00M
Financing Cash Flow-24.00M-684.00M-827.00M1.14B-974.00M-353.00M

Akzo Nobel NV Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price60.08
Price Trends
50DMA
60.15
Negative
100DMA
59.15
Positive
200DMA
57.92
Positive
Market Momentum
MACD
0.12
Positive
RSI
47.11
Neutral
STOCH
74.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AKZA, the sentiment is Neutral. The current price of 60.08 is below the 20-day moving average (MA) of 60.37, below the 50-day MA of 60.15, and above the 200-day MA of 57.92, indicating a neutral trend. The MACD of 0.12 indicates Positive momentum. The RSI at 47.11 is Neutral, neither overbought nor oversold. The STOCH value of 74.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NL:AKZA.

Akzo Nobel NV Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
€2.30B11.885.98%5.88%-0.46%182.29%
70
Outperform
€5.32B19.7014.32%2.27%6.09%-7.18%
68
Neutral
€987.42M14.538.84%3.69%-3.45%-5.55%
65
Neutral
€10.43B25.181.39%3.27%-1.57%-29.52%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
58
Neutral
€19.93B27.743.30%4.46%
57
Neutral
€921.22M104.341.94%0.68%5.17%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:AKZA
Akzo Nobel NV
60.08
2.68
4.67%
NL:AMG
AMG ADVANCED METALLURGICAL GROUP NV
29.50
13.72
86.93%
NL:APAM
Aperam S.A.
32.76
9.23
39.23%
NL:CRBN
Corbion NV
17.52
-6.28
-26.38%
NL:IMCD
IMCD N.V.
94.58
-52.42
-35.66%
NL:DSFIR
DSM-Firmenich AG
75.54
-36.17
-32.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025